Skip to main navigation Skip to search Skip to main content

Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1

  • Jean Philippe Arnault
  • , Christine Mateus
  • , Bernard Escudier
  • , Gorana Tomasic
  • , Janine Wechsler
  • , Emilie Hollville
  • , Jean Charles Soria
  • , David Malka
  • , Alain Sarasin
  • , Magalie Larcher
  • , Jocelyne Andrë
  • , Nyam Kamsu-Kom
  • , Lise Boussemart
  • , Ludovic Lacroix
  • , Alain Spatz
  • , Alexander M. Eggermont
  • , Sabine Druillennec
  • , Stephan Vagner
  • , Alain Eychène
  • , Nicolas Dumaz
    • Caroline Robert
  • Institut Gustave Roussy
  • Institut Curie
  • Université Paris Descartes
  • McGill University

Research output: Contribution to journal › Article › peer-review

115 Scopus citations

Fingerprint

Dive into the research topics of 'Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases